|
|
"the road to success is always under construction"
nOphthoCare
develops unique electronic eye glasses for treatment of ocular disorders
and nerve stimulation applications. The first product is targeted to
treat Amblyopia in children.
Enforcing
utilization of the weak eye by patching the healthy eye is the most
commonly used treatment for Amblyopia. However,
it is problematic and highly disliked by the children.
As a result, the treatment success rate is low (less than 50%).
The outcome is that children remain with their disorder for life. OpthoCare
has developed
Liquid Crystal Glasses for treating the disorder.
|
|
Send mail to
alon@partners500.com with
questions or comments about this web site.
|